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ABST RACT
Objective. To identify those who develop pulmonary embolism with Ddimer levels by evaluating pulmonary CT angiographies of patients who are
followed up with suspicion of coronavirus disease 2019 (COVID-19).
Methods. Patients who were followed up in a community hospital with
suspicion of COVID-19 and underwent Pulmonary CT angiography
examination were evaluated. Clinical and demographic parameters and DDimer values for patients with and without pulmonary embolism were
evaluated in the pulmonary CT angiogram. Results. During the COVID-19
pandemic, Thorax CT examination was performed in our center for
suspicion or follow-up of COVID-19 infection in 3396 patients. Pulmonary
CT angiography was applied to 312 (9.2%) of these cases. Of these 312
patients, 141 were identified as COVID-19 patients. Acute pulmonary
embolism was detected in 33 (23.4%) of 141 patients with COVID-19 and
pulmonary CT angiogram. D-dimer levels (5964.97±4036.8 μg/L) of
patients with COVID-19 infection and pulmonary embolism were
significantly higher than D-dimer levels (972.4±1766.8 μg/L) of patients
without pulmonary embolism. In patients with COVID-19 infection, a Ddimer value higher than 1013 μg/L was determined as a cut-off value with
100% sensitivity for the presence of pulmonary embolism. Conclusions. For
those struggling with the COVID-19 pandemic, pulmonary embolism should
be kept in mind if D-dimer values increase more than expected in the
presence of respiratory distress that Thorax CT findings cannot explain.

Introduction
In January 2020, a new coronavirus SARS-CoV-2 was
identified as the cause of the viral pneumonia epidemic in
Wuhan, China. This disease was later called coronavirus
disease 2019 (COVID-19), as it spread rapidly and
globally. The progression of COVID-19 includes primarily
serious respiratory complications [1]. Patients may have
fever, cough, abdominal pain and diarrhea. After the
COVID-19 outbreak, acute pulmonary embolism reports
related to COVID-19 have tended to increase. Several
studies have reported clinical cases with isolated
coagulopathy and pulmonary embolism with COVID-19
pneumonia [2-4]. Also, elevated D-dimer levels have been
reported in COVID-19 patients [5,6]. In addition, research
provides evidence for a relationship between the severity
of the disease and D-dimer levels [7]. The purpose of our
study was to identify those who develop pulmonary
embolism and detect if there is a correlation with D-dimer
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levels and pulmonary CT angiography findings in patients
who are followed up due to suspected COVID-19.

Materials and Methods
Patient group
This retrospective study was approved by Scientific
Research Committee in the structure of Ministry of Health
for COVID-19 research. The study was also approved
(permit no: 135-24.09.20) by the institutional ethics
committee for human clinical investigations which
oversees the protocols in accordance with the Declaration
of Helsinki. Patients who were followed-up with suspicion
of COVID-19, and underwent pulmonary CT angiography
between March 13 and May 20 at the Training and
Research Public Hospital, were evaluated. Clinical and
demographic parameters and D-Dimer values for patients
with and without pulmonary embolism were evaluated in
the pulmonary CT angiogram.
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Pulmonary CT Angiography
In our center, 128-multidetector tomography device
(Optima CT660, General Electric Healthcare Systems,
Milwaukee, USA) was used for examinations. Our
standard display parameters: 120 kVp, 150-300 mAs,
section thickness 1 mm and 0.6-1.4 pitch is determined
depending on body size. “SmartPrep” protocol (GE
Healthcare) was used as the monitoring system for the
injection of contrast medium. SmartPrep is a feature that
provides real-time tracking of contrast in part of its
intended area. Follow-up images are taken as a low dose
until the contrast medium reaches the preferred point and
scanning is initiated by the operator. In our examinations,
50-60 mL of iodinated contrast medium was injected
through the antecubital vein at a rate of 4.0 mL/s with an
18-to-20-gauge cannula. Images were reconstructed in the
mediastinal and parenchymal windows with a slice
thickness of 1 mm. The location of the pulmonary
embolism by a single radiologist classified the main
pulmonary arteries, lobar, segmental according to the most
proximal location of the filling defect.
Computed Tomography without contrast-media was
performed in patients who were not suspected of
pulmonary embolism and who requested CT for diagnosis
or follow-up in terms of COVID-19 pneumonia. Nonenhanced chest CT is preferably performed by using a lowradiation-dose protocol to minimize radiation burden.
Laboratory analysis
D-dimer levels were recorded for all patients with
pulmonary CT angiography. The last D-dimer
measurements of the patients before the CTPA
examination were evaluated. All patients with pulmonary
CT angiography were evaluated with the Reverse
Transcription Polymerase Chain Reaction (RT-PCR) test
results for SARS-CoV-2. Necessary samples were
obtained by nasopharyngeal swab. If necessary, second or
third sampling was done using sputum or bronchoalveolar
lavage. Any positive results were classified as confirmed
COVID-19 infection. In a limited group of patients, in the
early period of the pandemic, non-contrast thorax CT
examination was used for diagnosis due to the suspicion of
false negativity for PCR tests and late test results. In
addition to PCR positive patients, Thorax CT images of
RT-PCR negative patients were reviewed for comparison
by a radiologist with 15 years of experience (AV), and
patients were evaluated as COVID-19 in the presence of
typical lung parenchymal lesions (bilateral and peripheral
ground-glass opacities and / or alveolar consolidation) for
COVID-19 [7,8].
Statistical Analysis
Student t test was used for comparing the parameters
between the two groups (Mean, Standard deviation,
frequency). ROC curve analysis was used to determine the
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specificity and sensitivity values of D-dimer values and
cut-off values. Significance was evaluated at the level of
p<0.05. For all analyses, Statistical Package for the Social
Science 22 (version 22 for Windows; SPSS, Turkey)
program was used.

Results
The flow chart of all patients who applied to the
emergency department between 13 March and 20 May
2020 in our public hospital, who underwent CT scan, is
shown in Figure 1.

Figure 1. Flowchart of the study.
During this time, Thorax CT examination was
performed in 3396 patients for suspicion or follow-up of
COVID-19 infection. Pulmonary CT angiography was
applied to 312/3396 (9.2%) of these cases. Of these 312
patients, 141 patients were classified as COVID-19
infections (111 patients were positive RT-PCR and 30
patients were positive Thorax CT). The reason for
requesting CT angiography in these patients was high DDimer values in 88/141 (62%) patients, and respiratory
distress in 53/141 (38%) patients that could not be
explained by Thorax CT findings. 83 of our patients were
male (59%) and 58 were female (41%). The age range of
our patients was 23-95, and the mean age was calculated as
64.88±18.6 for male patients, 61.04±17.1 for female
patients and 62.62±17.8 for all patients. Acute pulmonary
embolism was detected in 33 (23.4%) of 141 patients with
COVID-19 and pulmonary CT angiogram (Figures 2, 3).
There were no signs of pulmonary embolism in 108
patients (76.6%). Relevant clinical and tomography data
are summarized in Table 1 and Table 2.
D-dimer levels (5964.97±4036.8 μg/L) of patients with
COVID-19 infection and pulmonary embolism were
significantly higher than D-dimer levels (972.4±1766.8
μg/L) of patients without pulmonary embolism (p<0.05).
In follow-up of 141 patients, 21/33 (64%) of patients with
pulmonary embolism and 19/108 (18%) of patients without
pulmonary embolism needed intensive care treatment
(p<0.05). Follow-up resulted in death in 10/33 (30%) of
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patients with pulmonary embolism and in 5/108 (4.6%) of
patients without pulmonary embolism (p<0.05) (Table 1).
In patients with COVID-19 infection, a D-dimer value
greater than 1013 μg/L had 33/33 (100%, 95% CI)
sensitivity and 78/108 (72%, 95% CI) specificity for the
presence of pulmonary embolism.

Figure 2. Pulmonary computed tomographic angiography
(PCTA) demonstrating saddle pulmonary embolism (PE)
as well as emboli partially obstructing both main
pulmonary arteries. A 33-year-old male patient has been
followed for 4 days with the diagnosis of COVID-19, and
PCTA was performed due to the increased dyspnea with a
rapid increase in D-dimer values.

The D-dimer levels of 171 patients whose PCR tests for
COVID-19 were negative but were applied CTPA due to
increased D-dimer levels were found to be 711 ± 416.5 μg
/ L. Pulmonary embolism was detected in 13 (7.6%) of 171
patients with negative COVID-19 tests.

Figure 3. Axial CT angiography scan of the chest shows
filling defects in the left lower lobe pulmonary arteries
representing clots (mediastinal window) and findings
compatible with COVID-19 pneumonia (lung window).

Table 1. Patient Demographics. The values are given as average/median PE: Pulmonary embolism.
Total
(n, % or SD)

With PE
(n, % or SD)

Without PE
(n, % or SD)

n=141

n=33

n=108

p value

62.62±17.8

65.52±18.5

61.73±17.5

.286

69(49)

17(52)

52(48)

.425

2191.7±3231.6

6034.7±3950.7

1017.5±1746.4

.001

ICU Hospitalization

40(28)

21(64)

19(18)

.001

Mortality

15(11)

10(30)

5(4.6)

.001

Age (years)
Male
D-dimer (μg /L)

Table 2: Location of embolus on Chest CT
N, %
Main pulmonary artery

10 (30.3)

Lobar artery

12 (36.4)

Segmental artery

6 (18.2)

Subsegmental artery

5 (15.1)

Total

33 (100)
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Discussions
Despite the need for improvement in infectious
involvement in the lung parenchyma in COVID-19
patients, high oxygen requirement continues and it may
even increase due to the development of thromboembolic
disease [9]. Myocardial damage has been reported to be
associated with a fatal course in COVID-19 patients, with
mortality rates reaching 37% in patients without prior
cardiovascular disease but with high troponin levels [10].
Previous studies have shown poor prognosis in COVID-19
cases, with low comorbidity in patients with severe
comorbidity, with low platelet levels, increased d-dimer
levels, and increased prothrombin levels [11]. D-dimer
levels higher than 1 μg/mL in COVID-19 patients have
been identified as an important risk factor for mortality
[12]. Autopsy reports of COVID-19 patients showed
microtrombus in the lungs and other organs with bleeding
focus [13,14]. These findings show that cytokine storm and
associated hypoxaemia lead to severe endothelial
dysfunction, causing intravascular coagulation and
thromboembolic
complications.
Although
some
underlying conditions have affected the coagulation
process in these patients, the hypothesis that
hypercoagulability is due to endothelial dysfunction makes
sense. Case studies support observations that show that
anticoagulation reduces mortality rates for COVID-19
patients [15]. Follow-up of diffuse intravascular
coagulation and measurement of platelet counts, D-dimer
and fibrinogen levels, assessment of the International
Society on Thrombosis and Haemostasis scores may be
useful for early diagnosis of PE in patients with COVID19 [9]. A normal level of D-dimer may enable the
exclusion of pulmonary embolism in patients who are
clinically unlikely to have PE. However, the increase in Ddimer level hinders the use of thrombosis as a precise
marker due to lack of specificity. The European Society of
Radiology and the European Society of Thoracic Imaging
recommend performing contrast CT to exclude PE if
additional oxygen is needed in patients with COVID-19
pneumonia with limited disease spread [16]. Similarly, the
European Society of Cardiology recommends CTPA
before the patient leaves the radiology department if the
findings obtained with non-contrast CT are not advanced
enough to explain severe respiratory failure [17].
It has been observed that pulmonary embolism and
deep vein thrombosis (DVT) occur in other viral
pneumonias, but not as often as in COVID-19 patients. It
was reported that seven (5.9%) of 119 people who applied
to the hospital with influenza A H1N1 virus infection
developed thrombotic vascular events, one of which was
PE and three were DVT [18].
In our center, which is one of the sites designated as a
pandemic hospital, we evaluated patients admitted with the
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suspicion of COVID-19. The use of the D-dimer test is not
recommended due to false positive results during clinical
evaluation. Although there is no evidence of pneumonia in
the COVID-19 patients to explain the respiratory distress
in the non-contrast Thoracic CT examination, pulmonary
CT angiography is recommended with high risk in case of
severe respiratory distress and increased oxygen support
requirement. It is recommended to perform D-dimer tests
in patients with low and moderate risk of pulmonary
embolism, and CT angiography if D-dimer results are
positive. Because D-dimer values increase with age [19], it
is recommended to accept age-adjusted limit values (such
as, age x 10 μg/L) for the D-dimer instead of a fixed cutoff value. Although there is no pulmonary embolism in
COVID-19 patients, increased D-dimer levels have been
reported compared to normal [20]. In our center, D-dimer
levels above 500 μg/L in COVID-19 patients are
considered sufficiently high in order to request pulmonary
CT angiography. All of the patients included in the study
were positive for the RT-PCR test or with typical signs of
COVID-19 pneumonia on Thoracic CT examination.
Acute pulmonary embolism was present in 33/141 (23.6%)
of the patients. This rate of pulmonary embolism is
significantly higher than the rates encountered in critically
ill patients (1.3%) [21] or emergency service patients (3 to
10%) without COVID-19 infection [22].
In our patient population, a D-dimer threshold of 1013
μg/L detected all patients with pulmonary embolism on
chest CT. This 1013 μg/L threshold is a value between
2660 [9], 2400 [23] and 900 [5] previously reported. These
cut-off values are normally higher than the cut-off values
used to exclude pulmonary embolism, as COVID-19
patients have increased D-dimer levels without pulmonary
embolism, which may be associated with a systemic
inflammatory response [24].
Hydroxychloroquine and favipiravir treatment was
administered to patients who were diagnosed with COVID19 in the early period of the pandemic in which patients
admitted to the study were followed, but anticoagulants
were not used for routine prophylaxis. At the time of
writing the article, 2x60 mg of enoxaparin sodium was
added to the routine treatment protocol of patients with
COVID-19 pneumonia. Although a more detailed
assessment is required, after anticoagulant prophylaxis was
initiated, there was a decrease in high D-dimer levels and
the need for CTPA.
Our study has several limitations. First, it is not possible
to accurately determine the incidence of PE in COVID-19
patients since CTPA examination is not performed in all
patients. Since our study was conducted in a retrospective
manner, it was not possible to determine exactly why PE
was suspected in terms of the examination decision in all
patients. For similar reasons, the comorbidities of patients
in terms of thromboembolism and past venous thrombosis
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histories could not be evaluated. In addition, patients were
not evaluated for deep vein thrombosis.

Highlights
✓ Increased D-dimer levels are often seen in patients
with COVID-19 pneumonia.
✓ There appears to be a strong association between high
D-dimer levels and thrombotic complications in
COVID-19 patients.
✓ Prophylaxis with anticoagulant agents may improve
prognosis in patients with COVID-19 pneumonia.

Conclusions
Although performed at a single center and with a
limited number of patients, we our study may provide
useful information for those fighting the COVID-19
pandemic. In the presence of respiratory distress that
thorax CT findings cannot explain, pulmonary embolism
should be kept in mind if D-dimer values increase more
than expected. Our findings may provide guidance in
making a decision for pulmonary CT angiography. In
addition, studies with more patients are required to
establish consensus regarding the use of anticoagulants as
prophylactic in COVID-19 patients whose clinical
situation has deteriorated.
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